(Q35266160)

English

Incidence of therapy-related myeloid neoplasia after initial therapy for chronic lymphocytic leukemia with fludarabine-cyclophosphamide versus fludarabine: long-term follow-up of US Intergroup Study E2997.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

Incidence of therapy-related myeloid neoplasia after initial therapy for chronic lymphocytic leukemia with fludarabine-cyclophosphamide versus fludarabine: long-term follow-up of US Intergroup Study E2997. (English)

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

chronic myeloid leukemia

0 references

chronic lymphocytic leukemia

1 reference

based on heuristic

inferred from title

Martin S. Tallman

15

object named as

Martin S Tallman

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

10

object named as

John C Byrd

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

Hillard M. Lazarus

5

object named as

Hillard M Lazarus

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

Frederick R. Appelbaum

12

object named as

Frederick R Appelbaum

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

Richard A. Larson

13

object named as

Richard A Larson

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

Elisabeth Paietta

9

object named as

Elisabeth M Paietta

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

14

object named as

Mark R Litzow

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

author name string

Mitchell R Smith

1

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

Donna Neuberg

2

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

Ian W Flinn

3

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

Michael R Grever

4

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

Jacob M Rowe

6

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

Gordon Dewald

7

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

John M Bennett

8

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

Mohamad A Hussein

11

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

language of work or name

0 references

publication date

29 July 2011

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

118

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

13

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

3525-3527

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

Evidence-based mini-review: the role of alkylating agents in the initial treatment of chronic lymphocytic leukemia patients with the 11q deletion

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3186330

27 July 2018

Therapy-related myelodysplastic syndrome and acute myeloid leukemia following fludarabine combination chemotherapy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3186330

27 July 2018

Addition of rituximab to fludarabine and cyclophosphamide in patients with chronic lymphocytic leukaemia: a randomised, open-label, phase 3 trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3186330

27 July 2018

Long-term results of the fludarabine, cyclophosphamide, and rituximab regimen as initial therapy of chronic lymphocytic leukemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3186330

27 July 2018

Phase III trial of fludarabine plus cyclophosphamide compared with fludarabine for patients with previously untreated chronic lymphocytic leukemia: US Intergroup Trial E2997.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3186330

27 July 2018

Early results of a chemoimmunotherapy regimen of fludarabine, cyclophosphamide, and rituximab as initial therapy for chronic lymphocytic leukemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3186330

27 July 2018

Therapy-related myeloid leukemia.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3186330

26 September 2018

Comprehensive assessment of genetic and molecular features predicting outcome in patients with chronic lymphocytic leukemia: results from the US Intergroup Phase III Trial E2997.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3186330

26 September 2018

Therapy-related myeloid leukemias are observed in patients with chronic lymphocytic leukemia after treatment with fludarabine and chlorambucil: results of an intergroup study, cancer and leukemia group B 9011.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3186330

26 September 2018

11q23 balanced chromosome aberrations in treatment-related myelodysplastic syndromes and acute leukemia: report from an international workshop

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3186330

26 September 2018

Second malignancies as a consequence of nucleoside analog therapy for chronic lymphoid leukemias

1 reference

https://pubmed.ncbi.nlm.nih.gov/21803850

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1182/BLOOD-2011-03-342485

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35266160&oldid=2001234008"